ELISA automation: IVD and non-IVD labs now have an affordable solution to ease their workflow

Hamilton Robotics has launched a new module for the Microlab STAR workstation that automates enzyme-linked immunoabsorbant assays (ELISAs).
Register for free to listen to this article
Listen with Speechify
0:00
1:00

Hamilton Robotics
 
Hamilton Robotics has launched a new module for the MicrolabSTAR workstation that automates enzyme-linked immunoabsorbant assays (ELISAs).Scalability of ELISA assays can be complex for high-throughput labs and theyface the challenge of processing several plates in parallel with multipletime-sensitive steps. Automating this task has the added benefits of improvingquality and traceability and minimizing reagent consumption. Hamilton's newMicrolab ELISA STARlet workstation integrates precision liquid-handlinginstrumentation with multiple devices and sophisticated software.
 

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Characterizing lipid nanoparticles for RNA therapeutic development
Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue